Impact of COVID-19 and Inflammatory Bowel Disease

July 7, 2021

Get highlights from the Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada report. Experts and co-authors of the report review the epidemiology of COVID-19 in Canada; risk factors for persons with IBD and medications; the impact of COVID-19 in children, families, seniors, and pregnant people with IBD; mental health and wellness; vaccines; healthcare services; and future policy implications.

Click here to download a PDF of the 2021 Impact of COVID-19 and IBD in Canada report.

Featured Panelists:

Dr. Lesley Graff (PhD, Cpsych), Clinical Health Psychologist, Department Head, Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba

Dr. Charles Bernstein (MD, FRCPC), Distinguished Professor of Medicine Head, Section of Gastroenterology, Program Director of the Gastroenterology Postgraduate Training Program, Director of the Inflammatory Bowel Disease Clinical and Research Centre, University of Manitoba

Dr. Ellen Kuenzig (PhD), Senior Research Associate, Epidemiologist, Inflammatory Bowel Disease Centre, SickKids Hospital, Person living with IBD

Dr. Cynthia Seow (MBBS, MSc, FRACP), Pregnancy and IBD Specialist, Associate Professor, Division of Gastroenterology and Hepatology, Departments of Medicine and Community Health Sciences, University of Calgary

Dr. Laura Targownik (MD, MSHS, FRCPC), Associate Professor of Medicine Departmental Division Director (Gastroenterology), University of Toronto Chair for Diversity and Equity, Canadian Association of Gastroenterology Staff Gastroenterologist, Mount Sinai Hospital

Dr. Deanna Gibson (PhD), Associate Professor, Biology, University of British Columbia, Okanagan Campus

Dr. Joseph Windsor (PhD), Research Associate, Medicine, Knowledge Translator, Inflammatory Bowel Disease Unit, University of Calgary

Dr. Sanjay Murthy (MD, FRCPC), Assistant Professor, Medicine, Clinician Investigator, Division of Gastroenterology, Associate Scientist in the Clinical Epidemiology Program, Ottawa Hospital Research Institute, University of Ottawa, Member of the Ottawa Hospital IBD Centre

Dr. Stephanie Coward (PhD), Research Associate, Medicine, Epidemiologist, Inflammatory Bowe Disease Unit, University of Calgary


Dr. Gilaad Kaplan (MD, MPH, FRCPC), Professor of Medicine, Gastroenterologist and Epidemiologist, Departments of Medicine and Community Health Sciences, University of Calgary, Past Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada l Twitter: @gilkaplan

Dr. Eric Benchimol (MD, PhD, FRCPC), Professor, Pediatric Gastroenterologist, Department of Paediatrics, The Hospital for Sick Children (SickKids) and University of Toronto, Division of Gastroenterology, Hepatology and Nutrition, SickKids, NASPGHAN Canadian Councilor, Chair of the Scientific and Medical Advisory Council, Crohn's and Colitis Canada | Twitter: @ericbenchimol

Dr Benchimol and Dr Kaplan photos

Want to help boost our research initiatives?

Text CURE to 20222 to donate $25 to Crohn’s and Colitis Canada’s critical research projects.


  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.